Group of disease processes characterized by insufficient perfusion/ oxygenation to myocardium.
Includes:
Angina Pectoris
Myocardial Infarction
Heart Failure with Preserved EF
Beta Blockers
Nitrates
Calcium Channel Blockers
Designed by Nobel Prize winner Sir James Black.
Counteract adverse effects of adrenergic stimulation.
Decrease myocardial oxygen demand and reduce angina symptoms.
Beta 1:
Located on cardiac sarcolemma
Adenylyl Cyclase System (AC) activated
AC produces cyclic adenosine monophosphate cAMP
Opens calcium channels
Promotes calcium uptake
Positive Inotropic, Chronotropic, and Dromotropic effects
Beta 2:
Located in bronchial and vascular smooth muscle
Beta 3:
Located in endothelial tissue
Blocks beta adrenergic receptors
Negative Inotropic (lowers contractility)
Negative Chronotropic (lowers rate)
Lowers myocardial oxygen consumption
Prevents epinephrine and norepinephrine from binding to receptors.
Inhibition of SA node/ AV node
Shortens myosin and actin interaction
Switches myocardial metabolism from fatty acids to glucose.
Plasma half life: Amount of time for 50% of drug concentration to disappear from plasma
Protein Binding: Extent at which drug binds to plasma proteins, especially albumin and alpha-1-acid glycoprotein (only unbound medication is active).
First pass hepatic metabolism: Substance enters portal vein from GI system, liver removes substance effectively stopping distribution.
Cardio Non-Cardio-Selective: Affects the heart and respiratory system
Cardio-Selective: Targets cardiac beta 1 receptors
Vasodilatory-Non-Selective: Works on heart and dilates blood vessels
Vasodilatory Selective: Selective for Beta 1 receptors and vasodilates through different pathway
Hydrophilic:
Excreted by kidneys
Carteolol
Nadolol
Atenolol
Lipophilic:
Metabolized by liver
More prone to interactions
Metoprolol (Lopressor)
Carvedilol (Coreg)
Labetolol
Propranolol
Angina Pectoris
Acute Coronary Syndromes
Early STEMI
CVA
Vascular Surgery
Classic effort angina tends to be reversable
Inadequate coronary vasodilation
Increased myocardial oxygen demand
Any beta blocker will work in the absence of other diseases
Management based on risk stratification
Anti-thrombolytic therapy
In hospital quadruple therapy includes beta blockers, statins, ACE inhibitors and antiplatelet therapies
Useful for ongoing chest pain, tachycardia, hypertension, ventricular arrhythmias
In USA only Metoprolol and Atenolol are available as IV therapies for acute MI
B_1 selective agents shown to reduce stroke
Non-selective Propranolol modestly useful
Protective effect
Death from cardiac causes and MI reduced
Not helpful for low cardiac risk patients
Severe Bradycardia
High Degree Heart Block
Cardiogenic Shock
Untreated LV Failure
Severe Asthma or Bronchospasm
Mild Asthma or Bronchospasm
1st line agents for angina
Reduce myocardial oxygen demand
Vasodilator
Increases cyclic guanosine monophosphate
Glyceryl Trinitrate
Isosorbide Dinitrate
Reduces preload due to vasodilation and decreased venous return
Reduces afterload due to vasodilation
Improves coronary perfusion (more direct effect)
Reduced renal and visceral perfusion
Administered sublingually due to high first pass metabolism.
Short half life
Too much use can create tolerance
Angina
MI and Acute Coronary Syndromes
Esophageal Spasm
Viagra
Cialis
Hypotension
Hypovolemia
Constrictive Pericarditis
Headache
Hypotension
Tachycardia
Facial Flushing
Calcium sustains contraction
Increases interaction of myosin and actin
Calcium channel blockers inhibit movement of calcium ions into cells
Bind to L-type calcium channels
L-type calcium channels are found on cardiomyocyte surfaces and blood vessels
Dihydropyridines:
Affect blood vessels
Used to control blood pressure
Relaxes smooth muscle
Widends vessel
Non-Dihydropyridines:
Affect the heart
Reduce contractility
Slow heart rate
Reduce conduction rate
Indications:
Angina
High Blood Pressure
Contraindications:
Heart Failure
Hypotension
Heart Block
Sick Sinus Syndrome
Drug Interactions
Fatigue/ Dizziness
Heart Failure
Edema